Immunicom is developing a non-drug-based cancer therapy with the potential to reduce treatment side effects, enhance therapy response rates and improve cancer patients’ quality of life – all at significantly lower costs and without the side effects and complications prevalent in existing immunotherapy approaches. Immunicom's cancer therapy has the potential to allow the body’s natural immune system to directly attack the cancer while enhancing the effects of other cancer treatments which may be used concurrently.
At Immunicom we are reimagine how healing should be.
Company Details
- Employees
- 22
- Founded
- -
- Address
- 6048 Cornerstone Court West,
- Industry
- Biotechnology
- Website
- immunicom.com
- Keywords
- Janux Therapeutics.
- HQ
- San Diego, CA
Immunicom, Inc. Questions
Immunicom, Inc.'s website is immunicom.com
Immunicom, Inc.'s LinkedIn profile is https://www.linkedin.com/company/immunicom
Immunicom, Inc. has
22 employees.
View email and phone details for 22
employees at Immunicom, Inc..
Immunicom, Inc.'s industry is
Biotechnology
Immunicom, Inc.'s top competitors are
Szaomics,
Adcentrx Therapeutics,
Innovo Therapeutics,
Kumquat Biosciences Inc.,
Janux Therapeutics,
Hesperos Inc.,
Nettwork Holdings,
Kura Oncology, Inc.,
Openx,
Primmune Therapeutics.
Immunicom, Inc.'s categories are Biotechnology
Immunicom, Inc.'s founding year is 2013
